Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & Administrative
Others
Ratios

Alx Oncology Holdings (ALXO) Other Non Operating Income (2020 - 2023)

Alx Oncology Holdings' Other Non Operating Income history spans 4 years, with the latest figure at -$29000.0 for Q4 2023.

  • For Q4 2023, Other Non Operating Income fell 1350.0% year-over-year to -$29000.0; the TTM value through Dec 2023 reached $389000.0, up 1720.83%, while the annual FY2025 figure was -$36000.0, 80.0% down from the prior year.
  • Other Non Operating Income for Q4 2023 was -$29000.0 at Alx Oncology Holdings, down from -$1000.0 in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $324000.0 in Q2 2023 and bottomed at -$305000.0 in Q2 2020.
  • The 4-year median for Other Non Operating Income is -$6500.0 (2022), against an average of -$21437.5.
  • The largest YoY upside for Other Non Operating Income was 6580.0% in 2023 against a maximum downside of 1350.0% in 2023.
  • A 4-year view of Other Non Operating Income shows it stood at -$212000.0 in 2020, then skyrocketed by 64.62% to -$75000.0 in 2021, then skyrocketed by 97.33% to -$2000.0 in 2022, then crashed by 1350.0% to -$29000.0 in 2023.
  • Per Business Quant, the three most recent readings for ALXO's Other Non Operating Income are -$29000.0 (Q4 2023), -$1000.0 (Q3 2023), and $324000.0 (Q2 2023).